Hartman Institute for Therapeutic Organ Regeneration

A computational approach to identify cellular heterogeneity and tissue-specific gene regulatory networks.

TitleA computational approach to identify cellular heterogeneity and tissue-specific gene regulatory networks.
Publication TypeJournal Article
Year of Publication2018
AuthorsJambusaria A, Klomp J, Hong Z, Rafii S, Dai Y, Malik AB, Rehman J
JournalBMC Bioinformatics
Volume19
Issue1
Pagination217
Date Published2018 Jun 07
ISSN1471-2105
KeywordsCells, Computational Biology, Databases, Factual, Gene Expression Profiling, Gene Regulatory Networks, Genetic Heterogeneity, Humans, Organ Specificity, Phenotype, Transcription Factors, Transcriptome
Abstract

<p><b>BACKGROUND: </b>The heterogeneity of cells across tissue types represents a major challenge for studying biological mechanisms as well as for therapeutic targeting of distinct tissues. Computational prediction of tissue-specific gene regulatory networks may provide important insights into the mechanisms underlying the cellular heterogeneity of cells in distinct organs and tissues.</p><p><b>RESULTS: </b>Using three pathway analysis techniques, gene set enrichment analysis (GSEA), parametric analysis of gene set enrichment (PGSEA), alongside our novel model (HeteroPath), which assesses heterogeneously upregulated and downregulated genes within the context of pathways, we generated distinct tissue-specific gene regulatory networks. We analyzed gene expression data derived from freshly isolated heart, brain, and lung endothelial cells and populations of neurons in the hippocampus, cingulate cortex, and amygdala. In both datasets, we found that HeteroPath segregated the distinct cellular populations by identifying regulatory pathways that were not identified by GSEA or PGSEA. Using simulated datasets, HeteroPath demonstrated robustness that was comparable to what was seen using existing gene set enrichment methods. Furthermore, we generated tissue-specific gene regulatory networks involved in vascular heterogeneity and neuronal heterogeneity by performing motif enrichment of the heterogeneous genes identified by HeteroPath and linking the enriched motifs to regulatory transcription factors in the ENCODE database.</p><p><b>CONCLUSIONS: </b>HeteroPath assesses contextual bidirectional gene expression within pathways and thus allows for transcriptomic assessment of cellular heterogeneity. Unraveling tissue-specific heterogeneity of gene expression can lead to a better understanding of the molecular underpinnings of tissue-specific phenotypes.</p>

DOI10.1186/s12859-018-2190-6
Alternate JournalBMC Bioinformatics
PubMed ID29940845
PubMed Central IDPMC6019795
Grant ListR01-GM094220 / NH / NIH HHS / United States
P01 HL077806 / HL / NHLBI NIH HHS / United States
P01-HL060678 / NH / NIH HHS / United States
T32-HL007829 / NH / NIH HHS / United States
T32 HL007829 / HL / NHLBI NIH HHS / United States
R01-HL090152 / NH / NIH HHS / United States
R01-HL118068 / NH / NIH HHS / United States
P01 HL060678 / HL / NHLBI NIH HHS / United States

Weill Cornell Medicine
Hartman Institute for Therapeutic Organ Regeneration
1300 York Ave, Box 136 New York, NY 10065